Literature DB >> 8838119

Involvement of cell-mediated killing in apoptosis in histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease).

T Takakuwa1, S Ohnuma, J Koike, M Hoshikawa, H Koizumi.   

Abstract

Histiocytic necrotizing lymphadenitis, also called Kikuchi-Fujimoto (KF) disease, is a benign disorder characterized histologically by paracortical necrotic foci surrounded by histiocytic aggregates. We analysed affected lymph node tissues from 34 patients with the disease in an attempt to elucidate its histogenesis. The 'necrotizing' cells showed typical apoptotic changes, including cell shrinkage and condensed and fragmented nuclei. Apoptotic bodies with a peculiar ultrastructure were demonstrated, and DNA fragmentation was detected in these cells by in situ end labelling. Immunostaining for the apoptosis-regulating proteins bcl-2, bax, c-myc and p53 failed to show their involvement in KF disease. However, perforin, a killer cell-specific cytolytic protein essential for provoking apoptosis in target cells, was found to be expressed abundantly by the infiltrating cells, which were thought to be cytotoxic T-lymphocytes. Perforin-expressing cells were present in the apoptotic foci of 28 of the 34 patients (82.4%). Virtually no cells containing perforin granules were present in non-pathological regions, lymph node tissues from control subjects with reactive or tuberculous lymphadenitis or those from patients with KF disease with negligible apoptosis. Therefore, the 'necrosis' associated with KF disease appears to be attributable to trans apoptotic death of the killer cell target in the affected nodes. We propose that KF disease should be called apoptotic lymphadenitis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8838119     DOI: 10.1046/j.1365-2559.1996.267310.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  Involvement of DNase gamma in apoptotic DNA fragmentation in histiocytic necrotizing lymphadenitis.

Authors:  Yoshikazu Higami; Kazuo To; Hiroshi Ohtani; Kenta Masui; Keisuke Iwasaki; Daisuke Shiokawa; Sei-Ichi Tanuma; Isao Shimokawa
Journal:  Virchows Arch       Date:  2003-06-12       Impact factor: 4.064

2.  Kikuchi's lymphadenitis and carcinoma of the stomach.

Authors:  J M Radhi; L Skinnider; A McFadden
Journal:  J Clin Pathol       Date:  1997-06       Impact factor: 3.411

3.  Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy.

Authors:  S A Pileri; F Facchetti; S Ascani; E Sabattini; S Poggi; M Piccioli; D Rondelli; F Vergoni; P L Zinzani; P P Piccaluga; B Falini; P G Isaacson
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 4.  Kikuchi-Fujimoto and Kimura diseases: the selected, rare causes of neck lymphadenopathy.

Authors:  Katarzyna Mrówka-Kata; Dariusz Kata; Sławomira Kyrcz-Krzemień; Grzegorz Helbig
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-10-16       Impact factor: 2.503

5.  Kikuchi-fujimoto disease in a 30-year-old caucasian female.

Authors:  David J Archibald; Matthew L Carlson; Ray O Gustafson
Journal:  Int J Otolaryngol       Date:  2009-12-20

6.  Histiocytic necrotising lymphadenitis (Kikuchi-Fujimoto disease) in Saudi Arabia: clinicopathology and immunohistochemistry.

Authors:  Jaudah Al-Maghrabi; Hassan Kanaan
Journal:  Ann Saudi Med       Date:  2005 Jul-Aug       Impact factor: 1.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.